-
Signature
-
/s/ Todd P. Kelsey, by Kate A. Gitter, Attorney-in-Fact
-
Stock symbol
-
PLXS
-
Transactions as of
-
Nov 14, 2023
-
Transactions value $
-
-$1,647,799
-
Form type
-
4
-
Date filed
-
11/16/2023, 05:40 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
PLXS |
Common Stock, $.01 par value |
Sale |
-$210K |
-2K |
-1.85% |
$105.00 |
106K |
Nov 14, 2023 |
Direct |
F2, F3 |
transaction |
PLXS |
Common Stock, $.01 par value |
Sale |
-$214K |
-2K |
-1.89% |
$107.00 |
104K |
Nov 15, 2023 |
Direct |
F2 |
transaction |
PLXS |
Common Stock, $.01 par value |
Options Exercise |
|
+24.6K |
+23.64% |
|
128K |
Nov 16, 2023 |
Direct |
F4 |
transaction |
PLXS |
Common Stock, $.01 par value |
Tax liability |
-$1.22M |
-11.5K |
-8.99% |
$106.03 |
117K |
Nov 16, 2023 |
Direct |
|
holding |
PLXS |
Common Stock, $.01 par value |
|
|
|
|
|
10.1K |
Nov 14, 2023 |
401(k) |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
PLXS |
Performance Stock Units |
Award |
|
+8.53K |
+28.61% |
|
38.3K |
Nov 16, 2023 |
Common Stock, $.01 par value |
8.53K |
|
Direct |
F4 |
transaction |
PLXS |
Performance Stock Units |
Options Exercise |
|
-24.6K |
-64.07% |
|
13.8K |
Nov 16, 2023 |
Common Stock, $.01 par value |
24.6K |
|
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: